MCPARTLAND MARK A. 4
4 · VistaGen Therapeutics, Inc. · Filed Aug 6, 2018
Insider Transaction Report
Form 4
MCPARTLAND MARK A.
VP Corporate Development
Transactions
- Award
Stock Option (Right to Buy)
2018-08-05+150,000→ 150,000 totalExercise: $1.27Exp: 2028-08-05→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter.